Navigation Links
TREANDA New Drug Application for the Treatment of Chronic Lymphocytic Leukemia Granted Priority Review Status by FDA
Date:12/3/2007

FRAZER, Pa., Dec. 3 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH) today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted priority review designation to the TREANDA(R) (bendamustine HCl) New Drug Application (NDA) for the first-line treatment of patients with chronic lymphocytic leukemia (CLL). CLL is a slowly progressing blood and bone marrow disease with an estimated 15,000 new cases diagnosed every year in the United States. Cephalon filed the TREANDA NDA for CLL in September 2007 and the FDA will make a review decision by the end of March 2008.

"If approved, TREANDA will make a meaningful difference as the first new CLL treatment option approved by the FDA since 2001 and could be available as soon as the second quarter of 2008," said Dr. Lesley Russell, Executive Vice President, Worldwide Medical and Regulatory Operations.

The FDA assigns priority review to drugs that, if approved, would offer major advances in treatment or would provide treatment to patients where no adequate therapy exists. Priority review reduces the targeted NDA review time from 10 months to six months. FDA granted orphan drug status for TREANDA for CLL in August 2007, which would entitle Cephalon to a seven-year period of marketing exclusivity in the United States, if the product is approved for this indication.

About TREANDA

TREANDA is a rationally designed purine analog/alkylator hybrid. Preclinical data demonstrate that this rationally designed hybrid acts in two ways to kill cancer cells. TREANDA damages the DNA in cancer cells, which leads to the normal path of cell death (apoptosis). It also stops cancer cells from dividing to create new cancer cells. This dual-action of TREANDA may be attributable to its unique chemical design.

Cephalon holds exclusive rights to market and develop TREANDA in the United States. TREANDA is licensed from Astellas Pharma GmbH. Bendamustine HCl, the active ingredient in
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia
2. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
3. Investigational New Drug Application for Fat Melting Injections Cleared by the FDA
4. PreMD Provides Update on 510(k) Application for PREVU(x) POC
5. Mindray Selects Actel Low-Power Flash FPGAs for Demanding Medical Equipment Applications
6. Medical Services International Inc. Completes Testing for European Union (EU) Application
7. Pharsight Files Application for Nasdaq Capital Market Listing
8. PartsSource Awarded US Patent for PartsFinder(TM) Application
9. HealthCentral.com Launches Greeting Card Application on Facebook.com
10. FDA Accepts New Drug Application for Priority Review of Investigational HIV Treatment TMC125
11. FDA Accepts New Drug Application for Priority Review of Investigational HIV Treatment TMC125
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... 2015 Alcohol and Violence , The ... that drinking and driving has been the focus of ... time, the link between alcohol and crime received less ... violence and sexual assault, and their relationship to alcohol ... 5.3 million adults in America were drinking alcohol at ...
(Date:4/17/2015)... April 17, 2015 Consumers who prefer ... without modifications can now use the Insurance Pros USA ... insurance policy rates that are featured by leading companies ... plans that are offered are mixed between three of ... to 79. There are now term, universal and whole ...
(Date:4/17/2015)... April 17, 2015 Most dental patients ... restoration units are made overseas by foreign dental laboratories, ... labs remain unregulated in more than 40 states by ... National Association of Dental Laboratories has created the ... awareness among patients about the consequences that could be ...
(Date:4/17/2015)... The American College of Traditional Chinese Medicine (ACTCM) ... on April 29. The event will be held from 11 a.m. ... DeHaro St. in San Francisco, CA. , The agenda for the ... the DeHaro campus (room F), 11:10 a.m. – Introduction and ... Light lunch with current students, faculty and staff, 1 p.m. – ...
(Date:4/17/2015)... City, NJ (PRWEB) April 17, 2015 ... stored in the posterior pituitary and thought to help ... bonding between couples. To further substantiate this, new studies ... in the journal, Nature, and reported by Medical News ... have a powerful influence over maternal social behavior. The ...
Breaking Medicine News(10 mins):Health News:Narconon Arrowhead Raises Awareness on Alcohol Related Prevention 2Health News:Narconon Arrowhead Raises Awareness on Alcohol Related Prevention 3Health News:General Life Insurance Policy Rates Added to Quotation System at Insurance Website Online 2Health News:National Association Urges Transparency in Dental Industry 2Health News:American College of Traditional Chinese Medicine Hosts Open House 2Health News:Oxytocin Now Found to Help Diet Doc Patients Whose Weight Has Gotten out of Control Due to Emotional Eating Disorders 2Health News:Oxytocin Now Found to Help Diet Doc Patients Whose Weight Has Gotten out of Control Due to Emotional Eating Disorders 3
... infection known as bird flu in a 19-year-old soldier. ... Cheng, and said he was under treatment at a People's ... specify his unit or say which region he came from, ... ,Cheng developed symptoms of fever, coughing and pneumonia on May ...
... Boston Medical Center (BMC) and Boston University School of ... the human immunodeficiency virus (HIV), who also have ... hepatitis C virus (HCV). These findings appear in the ... ,Co-infection of HIV and HCV is a significant medical ...
... traffic injury, leads to neck pain, headache and other ... health care utilization. Although there are few effective ... that the type and intensity of treatment received shortly ... prognosis. A new study published in the June 2007 ...
... for vaccination of their stock against bird flu, but ... risks, experts warn. ,Nigeria to ... tackle H5N1.Through culling, quarantine, disinfecting and surveillance of affected ... disease incidence, according to Joseph Domenech, chief veterinary officer ...
... Mr Rob Mitchell, today said expensive private training courses ... for entry into medical school. ... as much as $1,700 to attend private training courses ... the Undergraduate Medical Admission Test (UMAT). ...
... actor Ryan Phillippes representatives are strongly denying the National Enquirer magazines ... other in the toilet at L.A. hot spot Les Deux ... singer star apparently followed Ryan to the washroom after he ... two groping and kissing each other!! The New York Daily source ...
Cached Medicine News:Health News:Persons With HIV and Alcohol Problems Co-infected With Hepatitis C 2Health News:Aggressive Treatment for Whiplash Does Not Promote Faster Recovery 2Health News:Concern Expressed Over Poor Quality Bird Flu Vaccine Used in Nigeria 2
(Date:4/16/2015)... Mindray Medical International Limited (NYSE: MR ... medical devices worldwide, announced today that it has ... Report on Form 20-F that included audited financial ... electronic version of Mindray,s Annual Report on Form ... at  http://ir.mindray.com  or  http://www.sec.gov . Investors ...
(Date:4/16/2015)... MOUNTAIN VIEW, Calif. , April 16, 2015  Alexza ... its fiscal quarter ended March 31, 2015 on Wednesday, May ... The Company will also host an investor conference call and ... Time to provide a company update and discuss the financial ... Internet, go to www.alexza.com , under the "Investors" link.  ...
(Date:4/16/2015)... , April 16, 2015 Today, Kenneth C. ... & Co., Inc., was elected chairman of the Board of ... Board meeting, PhRMA,s president and CEO John J. Castellani ... 2016.  New Officers Elected to PhRMA Board ... succeeds Ian C. Read , chairman and CEO of ...
Breaking Medicine Technology:Mindray Files Annual Report on Form 20-F with the U.S. Securities and Exchange Commission 2Alexza to Report 2015 First Quarter Financial Results and Provide Corporate Update on Wednesday, May 6, 2015 2Alexza to Report 2015 First Quarter Financial Results and Provide Corporate Update on Wednesday, May 6, 2015 3Merck Chairman and CEO Kenneth C. Frazier Becomes PhRMA Board Chairman 2Merck Chairman and CEO Kenneth C. Frazier Becomes PhRMA Board Chairman 3Merck Chairman and CEO Kenneth C. Frazier Becomes PhRMA Board Chairman 4Merck Chairman and CEO Kenneth C. Frazier Becomes PhRMA Board Chairman 5
... 2012   Psyche Systems Corporation and Aperio ... offer the most advanced anatomic pathology information system ... pathologists can immediately access, manage, and evaluate their ... LIS via intuitive step-by-step workflows. ...
... treatment of the fermented soy germ-based nutritional supplement containing ... cholesterol and improved vascular stiffness, all factors that occur ... peer-reviewed study reported in a poster at the Women,s ... the first to provide evidence that a daily supplement ...
Cached Medicine Technology:Psyche Systems Corporation and Aperio® Announce Availability of Their Fully Integrated Anatomic Pathology System 2Soy-Based S-equol Supplement Reduces Metabolic Syndrome Risk Factors 2Soy-Based S-equol Supplement Reduces Metabolic Syndrome Risk Factors 3Soy-Based S-equol Supplement Reduces Metabolic Syndrome Risk Factors 4Soy-Based S-equol Supplement Reduces Metabolic Syndrome Risk Factors 5
The cardiac blanket is pre-positioned at the waist during prep, unrolled upon closure of the saphenous vein graft incision, and inflated post-bypass....
The cardiac access blanket helps maintain normothermia and allows unrestricted access to the patient....
The full access underbody blanket is positioned on the procedure table before the patient arrives to the room....
The cath lab blanket, designed for use in the Cardiac Cath Lab, surrounds the patient with warm air and allows unrestricted access to the femoral artery....
Medicine Products: